Literature DB >> 15803359

Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.

William F Anderson1, Ismail Jatoi, Susan S Devesa.   

Abstract

BACKGROUND: Breast cancer is a heterogeneous and chronic disease with relapses and death occurring 25 years or more after primary diagnosis. Standard tumor characteristics are used to predict initial relapse or death, but their ability to estimate long-term patterns of failure may be limited.
METHODS: To further evaluate the significance of standard tumor features, we compared incidence and prognostic patterns in the National Cancer Institute's (NCI's) large-scale population-based Surveillance, Epidemiology, and End Results (SEER) program for high-risk versus low-risk breast cancers, i.e., size > 2.0 versus < or = 2.0 cm, lymph node positive versus negative, high versus low histologic grade, and hormone receptor negative versus positive expression, respectively. Data were stratified by age 50 years to approximate menopause.
RESULTS: High-risk versus low-risk breast cancers demonstrated two very different incidence and prognostic patterns. Age-specific incidence rates among women with high-risk tumors increased until age 50 years then flattened, whereas rates among women with low-risk tumors increased continuously with aging. Hazard rates for breast cancer death spiked sharply two years following primary breast cancer diagnosis among women with high-risk but not with low-risk tumors. Paradoxically, hazard function crossed over 6-8 years following breast cancer diagnosis, with hazard rates lower for high-risk than for low-risk breast cancers.
CONCLUSION: Distinct incidence and prognostic patterns among high-risk and low-risk breast cancers suggest a possible link between breast cancer etiology and outcome. These epidemiologic results appear to complement emerging molecular genetic techniques, showing distinct genotypes for high-risk and low-risk breast cancer phenotypes.

Entities:  

Mesh:

Year:  2005        PMID: 15803359     DOI: 10.1007/s10549-004-3777-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  41 in total

Review 1.  Genetic susceptibility loci for breast cancer by estrogen receptor status.

Authors:  Montserrat Garcia-Closas; Stephen Chanock
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

2.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

3.  Breast cancer adjuvant therapy: time to consider its time-dependent effects.

Authors:  Ismail Jatoi; William F Anderson; Jong-Hyeon Jeong; Carol K Redmond
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

4.  Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

Authors:  Tasha R Smith; Wen Liu-Mares; Beth O Van Emburgh; Edward A Levine; Glenn O Allen; Jeff W Hill; Isildinha M Reis; Laura A Kresty; Mark D Pegram; Mark S Miller; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2011-06-23       Impact factor: 4.944

5.  Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Authors:  Robert K Dearth; Jill K Hiney; Vinod K Srivastava; Alina M Hamilton; William L Dees
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-20

6.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

7.  Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.

Authors:  Lena U Rosenberg; Fredrik Granath; Paul W Dickman; Kristjana Einarsdóttir; Sara Wedrén; Ingemar Persson; Per Hall
Journal:  Breast Cancer Res       Date:  2008-09-19       Impact factor: 6.466

8.  Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.

Authors:  Stephanie Harkey Shirley; Joyce E Rundhaug; Jie Tian; Noirin Cullinan-Ammann; Isabel Lambertz; Claudio J Conti; Robin Fuchs-Young
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 9.  To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors.

Authors:  Cleo A Samuel; Laura C Pinheiro; Katherine E Reeder-Hayes; Jennifer S Walker; Giselle Corbie-Smith; Shekinah A Fashaw; Cheryl Woods-Giscombe; Stephanie B Wheeler
Journal:  Breast Cancer Res Treat       Date:  2016-09-06       Impact factor: 4.872

10.  Challenges in studying the etiology of breast cancer subtypes.

Authors:  Melissa A Troester; Theresa Swift-Scanlan
Journal:  Breast Cancer Res       Date:  2009-06-29       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.